Urs Jaisli - Roche Holding Insider

Roche Holding AG -- Switzerland Stock  

CHF 243.7  2.3  0.95%

Chief Compliance Officer

We currently do not have informatin regarding Urs Jaisli. This executive tanure with Roche Holding AG is not currenlty determined.
Age: 58        
41 61 688 11 11  http://www.roche.com

Management Efficiency

The company has return on total asset (ROA) of 15.0 % which means that it generated profit of $15.0 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 42.46 % meaning that it generated $42.46 on every $100 dollars invested by stockholders.
The company has accumulated 21.12 B in total debt with debt to equity ratio (D/E) of 83.5 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Roche Holding AG has Current Ratio of 1.26 suggesting that it may have difficulties to pay its financial obligations in time and when they become due.

Entity Summary

Roche Holding AG operates in the pharmaceuticals and diagnostics businesses worldwide. Roche Holding AG (ROG) is traded on Switzerland Exchange in Switzerland. It is located in Basel, and employs 91,747 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Roche Holding AG to your portfolio

Top Management

Roche Holding AG Leadership Team
Osamu Nagayama, CEO
Michael Varney, Executive
Silvia Ayyoubi, Executive
Sophie KornowskiBonnet, Executive
Paul Bulcke, Director
Beatrice Mauro, Director
Christoph Franz, Director
PerOlof Attinger, CEO
Roland Diggelmann, COO
Pius Baschera, Director, Ph.D
Peter Voser, Director
Gottlieb Keller, Executive, Ph.D
Urs Jaisli, Executive
Daniel ODay, COO, MBA
DeAnne Julius, Director
John Bell, Director, Ph.D
Andreas Oeri, Director, Ph.D
Andre Hoffmann, Chairman, MBA
John Reed, Executive, Ph.D
Alan Hippe, CFO
Stephan Feldhaus, Executive, Ph.D
F Hoffmann, Executive
Severin Schwan, CEO, Ph.D

Stock Performance

Roche Holding Performance Indicators